The Use of Antibiotics for Ventilator-Associated Pneumonia in the MIMIC-IV Database

10Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Purpose: By analyzing the clinical characteristics, etiological characteristics and commonly used antibiotics of patients with ventilator-associated pneumonia (VAP) in intensive care units (ICUs) in the intensive care database. This study aims to provide guidance information for the clinical rational use of drugs for patients with VAP. Method: Patients with VAP information were collected from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database, including their sociodemographic characteristics, vital signs, laboratory measurements, complications, microbiology, and antibiotic use. After data processing, the characteristics of the medications used by patients with VAP in ICUs were described using statistical graphs and tables, and experiences were summarized and the reasons were analyzed. Results: This study included 2,068 patients with VAP. Forty-eight patient characteristics, including demographic indicators, vital signs, biochemical indicators, scores, and comorbidities, were compared between the survival and death groups of VAP patients. Cephalosporins and vancomycin were the most commonly used. Among them, fourth-generation cephalosporin (ForGC) combined with vancomycin was used the most, by 540 patients. First-generati49n cephalosporin (FirGC) combined with vancomycin was associated with the highest survival rate (86.7%). More than 55% of patients were infected with Gram-negative bacteria. However, patients with VAP had fewer resistant strains (<25%). FirGC or ForGC combined with vancomycin had many inflammation-related features that differed significantly from those in patients who did not receive medication. Conclusion: Understanding antibiotic use, pathogenic bacteria compositions, and the drug resistance rates of patients with VAP can help prevent the occurrence of diseases, contain infections as soon as possible, and promote the recovery of patients.

References Powered by Scopus

International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia

910Citations
N/AReaders
Get full text

Brief introduction of medical database and data mining technology in big data era

394Citations
N/AReaders
Get full text

Data mining in clinical big data: the frequently used databases, steps, and methodological models

322Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Construction and validation of prognostic models in critically Ill patients with sepsis-associated acute kidney injury: interpretable machine learning approach

31Citations
N/AReaders
Get full text

A Prediction Model for In-Hospital Mortality of Acute Exacerbations of Chronic Obstructive Pulmonary Disease Patients Based on Red Cell Distribution Width-to-Platelet Ratio

7Citations
N/AReaders
Get full text

Association Between Albumin-Corrected Anion Gap and In-Hospital Mortality and Sepsis-Associated Acute Kidney Injury

4Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Yang, R., Huang, T., Shen, L., Feng, A., Li, L., Li, S., … Lyu, J. (2022). The Use of Antibiotics for Ventilator-Associated Pneumonia in the MIMIC-IV Database. Frontiers in Pharmacology, 13. https://doi.org/10.3389/fphar.2022.869499

Readers over time

‘22‘23‘24‘25036912

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

67%

Lecturer / Post doc 1

17%

Researcher 1

17%

Readers' Discipline

Tooltip

Medicine and Dentistry 3

38%

Computer Science 2

25%

Nursing and Health Professions 2

25%

Pharmacology, Toxicology and Pharmaceut... 1

13%

Save time finding and organizing research with Mendeley

Sign up for free
0